Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Tuberculosis | 67 | 2024 | 2001 | 5.900 |
Why?
|
Peru | 93 | 2024 | 884 | 3.920 |
Why?
|
Tuberculosis, Pulmonary | 32 | 2024 | 831 | 3.090 |
Why?
|
Mycobacterium tuberculosis | 33 | 2024 | 1903 | 2.240 |
Why?
|
Tuberculosis, Multidrug-Resistant | 24 | 2023 | 930 | 2.120 |
Why?
|
Antitubercular Agents | 30 | 2024 | 1373 | 1.890 |
Why?
|
Isoniazid | 8 | 2022 | 283 | 1.210 |
Why?
|
Latent Tuberculosis | 7 | 2024 | 224 | 0.880 |
Why?
|
Contact Tracing | 12 | 2024 | 271 | 0.810 |
Why?
|
Family Characteristics | 12 | 2024 | 1000 | 0.780 |
Why?
|
Rifampin | 10 | 2023 | 339 | 0.760 |
Why?
|
Sputum | 12 | 2024 | 502 | 0.750 |
Why?
|
Nitroimidazoles | 3 | 2022 | 117 | 0.530 |
Why?
|
HIV Infections | 16 | 2024 | 17275 | 0.470 |
Why?
|
Health Personnel | 8 | 2024 | 3311 | 0.430 |
Why?
|
Health Knowledge, Attitudes, Practice | 4 | 2017 | 3990 | 0.400 |
Why?
|
Adolescent | 56 | 2024 | 87888 | 0.380 |
Why?
|
Mass Screening | 9 | 2024 | 5425 | 0.370 |
Why?
|
Professional Competence | 1 | 2014 | 431 | 0.370 |
Why?
|
Prediabetic State | 3 | 2022 | 547 | 0.350 |
Why?
|
Medication Adherence | 5 | 2023 | 2155 | 0.330 |
Why?
|
Humans | 131 | 2024 | 758381 | 0.310 |
Why?
|
Mouth Mucosa | 2 | 2020 | 426 | 0.300 |
Why?
|
Antigens, CD1 | 2 | 2021 | 439 | 0.290 |
Why?
|
DNA, Bacterial | 4 | 2020 | 1456 | 0.290 |
Why?
|
Health Services Accessibility | 6 | 2024 | 5403 | 0.290 |
Why?
|
Young Adult | 40 | 2024 | 58808 | 0.290 |
Why?
|
Child | 42 | 2024 | 79813 | 0.280 |
Why?
|
Pyrazinamide | 2 | 2017 | 60 | 0.280 |
Why?
|
Child, Preschool | 28 | 2024 | 42058 | 0.280 |
Why?
|
Genome, Bacterial | 2 | 2024 | 770 | 0.280 |
Why?
|
BCG Vaccine | 4 | 2018 | 371 | 0.260 |
Why?
|
Adult | 61 | 2024 | 219916 | 0.260 |
Why?
|
Infant | 26 | 2024 | 36054 | 0.260 |
Why?
|
Lost to Follow-Up | 2 | 2024 | 123 | 0.260 |
Why?
|
Oxazoles | 3 | 2022 | 199 | 0.250 |
Why?
|
Delayed Diagnosis | 3 | 2024 | 463 | 0.250 |
Why?
|
Focus Groups | 4 | 2022 | 1382 | 0.250 |
Why?
|
Quantitative Trait Loci | 2 | 2024 | 2100 | 0.240 |
Why?
|
Sensitivity and Specificity | 8 | 2024 | 14641 | 0.240 |
Why?
|
Male | 70 | 2024 | 358742 | 0.230 |
Why?
|
Female | 74 | 2024 | 390316 | 0.230 |
Why?
|
Tuberculin Test | 6 | 2023 | 206 | 0.230 |
Why?
|
Prevalence | 12 | 2024 | 15646 | 0.230 |
Why?
|
Bivalvia | 1 | 2023 | 53 | 0.230 |
Why?
|
Breath Tests | 1 | 2024 | 297 | 0.220 |
Why?
|
Extensively Drug-Resistant Tuberculosis | 1 | 2023 | 85 | 0.210 |
Why?
|
Antiretroviral Therapy, Highly Active | 3 | 2019 | 1895 | 0.190 |
Why?
|
Infant, Newborn | 15 | 2024 | 26182 | 0.190 |
Why?
|
Private Sector | 1 | 2024 | 396 | 0.180 |
Why?
|
Microbial Sensitivity Tests | 7 | 2023 | 1945 | 0.180 |
Why?
|
Transportation | 1 | 2022 | 214 | 0.180 |
Why?
|
Cholesterol Ester Transfer Proteins | 1 | 2021 | 113 | 0.180 |
Why?
|
Trehalose | 1 | 2021 | 88 | 0.180 |
Why?
|
Esters | 1 | 2021 | 209 | 0.180 |
Why?
|
Cough | 1 | 2024 | 594 | 0.180 |
Why?
|
Prisons | 1 | 2022 | 174 | 0.180 |
Why?
|
Sulfhydryl Compounds | 1 | 2021 | 297 | 0.170 |
Why?
|
Prisoners | 1 | 2023 | 314 | 0.170 |
Why?
|
Middle Aged | 41 | 2024 | 219560 | 0.170 |
Why?
|
Qualitative Research | 8 | 2023 | 2976 | 0.170 |
Why?
|
Radiography, Thoracic | 2 | 2024 | 1296 | 0.160 |
Why?
|
HIV Long-Term Survivors | 1 | 2019 | 121 | 0.160 |
Why?
|
Gastric Juice | 1 | 2018 | 59 | 0.160 |
Why?
|
Antigens, CD1d | 1 | 2019 | 217 | 0.160 |
Why?
|
Amides | 1 | 2021 | 447 | 0.160 |
Why?
|
Drug Resistance, Multiple, Bacterial | 3 | 2018 | 586 | 0.160 |
Why?
|
Prospective Studies | 21 | 2024 | 54136 | 0.160 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2023 | 4567 | 0.160 |
Why?
|
Self Disclosure | 1 | 2019 | 249 | 0.160 |
Why?
|
Transients and Migrants | 1 | 2021 | 162 | 0.150 |
Why?
|
Vitamin E Deficiency | 1 | 2018 | 30 | 0.150 |
Why?
|
Antibiotics, Antitubercular | 1 | 2018 | 99 | 0.150 |
Why?
|
Immunoglobulin M | 1 | 2023 | 1529 | 0.150 |
Why?
|
Anti-HIV Agents | 2 | 2024 | 4504 | 0.150 |
Why?
|
Geologic Sediments | 1 | 2018 | 80 | 0.150 |
Why?
|
Specimen Handling | 2 | 2022 | 707 | 0.150 |
Why?
|
Tuberculosis Vaccines | 1 | 2017 | 48 | 0.150 |
Why?
|
National Health Programs | 2 | 2021 | 439 | 0.150 |
Why?
|
Suction | 1 | 2018 | 262 | 0.150 |
Why?
|
Directly Observed Therapy | 1 | 2018 | 139 | 0.140 |
Why?
|
Communicable Disease Control | 2 | 2021 | 842 | 0.140 |
Why?
|
Vitamin A Deficiency | 1 | 2017 | 88 | 0.140 |
Why?
|
Amino Acid Motifs | 1 | 2019 | 929 | 0.140 |
Why?
|
Health Facilities | 1 | 2022 | 578 | 0.140 |
Why?
|
Ethambutol | 1 | 2016 | 59 | 0.140 |
Why?
|
Linkage Disequilibrium | 1 | 2021 | 1996 | 0.140 |
Why?
|
Case-Control Studies | 8 | 2022 | 22031 | 0.130 |
Why?
|
Actigraphy | 1 | 2020 | 518 | 0.130 |
Why?
|
Comprehensive Health Care | 1 | 2017 | 123 | 0.130 |
Why?
|
Viral Load | 3 | 2023 | 3321 | 0.130 |
Why?
|
Hypersensitivity, Immediate | 1 | 2019 | 345 | 0.130 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2019 | 800 | 0.130 |
Why?
|
Amidohydrolases | 1 | 2016 | 162 | 0.130 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2020 | 611 | 0.130 |
Why?
|
Caregivers | 3 | 2023 | 2224 | 0.130 |
Why?
|
Risk Factors | 19 | 2024 | 73806 | 0.130 |
Why?
|
Selection, Genetic | 1 | 2020 | 868 | 0.130 |
Why?
|
Health Literacy | 1 | 2020 | 441 | 0.120 |
Why?
|
Parenting | 1 | 2021 | 695 | 0.120 |
Why?
|
Cross-Sectional Studies | 10 | 2024 | 25953 | 0.120 |
Why?
|
Th17 Cells | 1 | 2021 | 785 | 0.120 |
Why?
|
Socioeconomic Factors | 4 | 2022 | 7817 | 0.120 |
Why?
|
Immunologic Memory | 1 | 2021 | 1353 | 0.120 |
Why?
|
Anticholesteremic Agents | 1 | 2021 | 963 | 0.120 |
Why?
|
Income | 1 | 2023 | 1872 | 0.120 |
Why?
|
Treatment Outcome | 17 | 2023 | 64379 | 0.120 |
Why?
|
Entamoebiasis | 1 | 2013 | 12 | 0.120 |
Why?
|
Protozoan Infections | 1 | 2013 | 39 | 0.110 |
Why?
|
Amebiasis | 1 | 2013 | 33 | 0.110 |
Why?
|
Social Class | 1 | 2023 | 1999 | 0.110 |
Why?
|
Giardiasis | 1 | 2013 | 28 | 0.110 |
Why?
|
Blastocystis Infections | 1 | 2013 | 17 | 0.110 |
Why?
|
Age Factors | 10 | 2021 | 18357 | 0.110 |
Why?
|
Body Height | 1 | 2020 | 1567 | 0.110 |
Why?
|
Social Stigma | 2 | 2023 | 763 | 0.110 |
Why?
|
Bronchiectasis | 1 | 2015 | 139 | 0.110 |
Why?
|
Phylogeny | 1 | 2021 | 2774 | 0.110 |
Why?
|
Vitamin E | 1 | 2018 | 870 | 0.110 |
Why?
|
Diabetes Mellitus | 4 | 2020 | 5818 | 0.110 |
Why?
|
Urban Population | 2 | 2020 | 2023 | 0.110 |
Why?
|
Pharmaceutical Preparations | 1 | 2021 | 1090 | 0.110 |
Why?
|
Molecular Epidemiology | 1 | 2015 | 469 | 0.110 |
Why?
|
Dendritic Cells | 1 | 2024 | 2723 | 0.110 |
Why?
|
Primary Prevention | 1 | 2020 | 1185 | 0.110 |
Why?
|
Diagnostic Tests, Routine | 1 | 2018 | 787 | 0.110 |
Why?
|
Drug Resistance, Bacterial | 2 | 2017 | 1055 | 0.100 |
Why?
|
Feces | 1 | 2019 | 1457 | 0.100 |
Why?
|
Community Health Services | 1 | 2018 | 655 | 0.100 |
Why?
|
Breast Feeding | 1 | 2021 | 1355 | 0.100 |
Why?
|
Parents | 2 | 2017 | 3548 | 0.100 |
Why?
|
Disease Progression | 5 | 2021 | 13468 | 0.100 |
Why?
|
Host-Pathogen Interactions | 1 | 2021 | 1444 | 0.100 |
Why?
|
Mothers | 2 | 2021 | 2189 | 0.100 |
Why?
|
World Health Organization | 3 | 2023 | 1312 | 0.100 |
Why?
|
Antibodies, Viral | 1 | 2023 | 3142 | 0.100 |
Why?
|
Epidemics | 1 | 2017 | 512 | 0.090 |
Why?
|
Hyperglycemia | 1 | 2020 | 1368 | 0.090 |
Why?
|
Cost of Illness | 1 | 2021 | 1936 | 0.090 |
Why?
|
Nutritional Status | 2 | 2016 | 1607 | 0.090 |
Why?
|
Immunoglobulin G | 1 | 2023 | 4540 | 0.090 |
Why?
|
Binding Sites | 1 | 2019 | 6036 | 0.090 |
Why?
|
Mutation, Missense | 1 | 2020 | 2564 | 0.090 |
Why?
|
Medication Errors | 1 | 2017 | 784 | 0.090 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2023 | 10146 | 0.090 |
Why?
|
Clinical Protocols | 3 | 2022 | 1436 | 0.090 |
Why?
|
Logistic Models | 6 | 2023 | 13276 | 0.090 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 2 | 2015 | 3217 | 0.090 |
Why?
|
Weight Gain | 1 | 2020 | 2346 | 0.080 |
Why?
|
Vitamin D Deficiency | 1 | 2019 | 1377 | 0.080 |
Why?
|
Smoking Cessation | 1 | 2021 | 2049 | 0.080 |
Why?
|
Incidence | 8 | 2020 | 21273 | 0.080 |
Why?
|
Sexual Behavior | 1 | 2019 | 2158 | 0.080 |
Why?
|
Aged | 18 | 2024 | 168217 | 0.080 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2018 | 3774 | 0.080 |
Why?
|
Blood Glucose | 2 | 2021 | 6347 | 0.080 |
Why?
|
Macrophages | 1 | 2024 | 5737 | 0.080 |
Why?
|
Tobacco Smoke Pollution | 1 | 2014 | 812 | 0.080 |
Why?
|
Feasibility Studies | 4 | 2020 | 5199 | 0.080 |
Why?
|
Public Health | 1 | 2022 | 2658 | 0.080 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2020 | 2125 | 0.080 |
Why?
|
Cluster Analysis | 3 | 2021 | 2697 | 0.080 |
Why?
|
Adaptation, Psychological | 1 | 2019 | 2629 | 0.080 |
Why?
|
Nucleic Acid Amplification Techniques | 2 | 2023 | 328 | 0.080 |
Why?
|
T-Lymphocytes | 3 | 2021 | 10171 | 0.080 |
Why?
|
Interviews as Topic | 1 | 2015 | 2675 | 0.080 |
Why?
|
Health Behavior | 1 | 2019 | 2615 | 0.080 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2024 | 15773 | 0.070 |
Why?
|
Feeding Behavior | 2 | 2017 | 3183 | 0.070 |
Why?
|
Cohort Studies | 9 | 2024 | 41252 | 0.070 |
Why?
|
Patient Acceptance of Health Care | 4 | 2024 | 3175 | 0.070 |
Why?
|
Bacterial Proteins | 1 | 2021 | 3824 | 0.070 |
Why?
|
Emotions | 1 | 2019 | 2734 | 0.070 |
Why?
|
Triage | 2 | 2024 | 986 | 0.070 |
Why?
|
Glucose Tolerance Test | 2 | 2020 | 1172 | 0.070 |
Why?
|
Drug Therapy, Combination | 3 | 2023 | 6293 | 0.070 |
Why?
|
Genetic Predisposition to Disease | 3 | 2024 | 17768 | 0.070 |
Why?
|
Genotype | 5 | 2019 | 12945 | 0.070 |
Why?
|
Patient-Centered Care | 3 | 2022 | 1415 | 0.070 |
Why?
|
Sex Factors | 4 | 2021 | 10505 | 0.070 |
Why?
|
Healthcare Disparities | 1 | 2022 | 3362 | 0.070 |
Why?
|
Multivariate Analysis | 5 | 2019 | 12096 | 0.070 |
Why?
|
Quality Improvement | 1 | 2021 | 3806 | 0.060 |
Why?
|
Social Support | 3 | 2022 | 2153 | 0.060 |
Why?
|
Vitamin D | 1 | 2019 | 3283 | 0.060 |
Why?
|
Homosexuality, Male | 2 | 2024 | 1329 | 0.060 |
Why?
|
Area Under Curve | 2 | 2020 | 1632 | 0.060 |
Why?
|
Immunophenotyping | 2 | 2020 | 1871 | 0.060 |
Why?
|
Comorbidity | 2 | 2017 | 10495 | 0.060 |
Why?
|
Psychometrics | 1 | 2014 | 3050 | 0.060 |
Why?
|
Sleep | 1 | 2020 | 4745 | 0.060 |
Why?
|
Treatment Failure | 2 | 2023 | 2640 | 0.060 |
Why?
|
Clofazimine | 1 | 2023 | 41 | 0.060 |
Why?
|
Pilot Projects | 3 | 2022 | 8554 | 0.060 |
Why?
|
Exercise | 1 | 2020 | 5788 | 0.060 |
Why?
|
Longitudinal Studies | 4 | 2024 | 14481 | 0.050 |
Why?
|
Tuberculin | 1 | 2022 | 64 | 0.050 |
Why?
|
Odds Ratio | 3 | 2023 | 9650 | 0.050 |
Why?
|
Delivery of Health Care | 1 | 2021 | 5331 | 0.050 |
Why?
|
Smoking | 2 | 2021 | 9042 | 0.050 |
Why?
|
Reverse Transcription | 1 | 2022 | 47 | 0.050 |
Why?
|
Public Sector | 1 | 2024 | 265 | 0.050 |
Why?
|
Body Mass Index | 2 | 2017 | 12876 | 0.050 |
Why?
|
Retrospective Studies | 6 | 2023 | 80170 | 0.050 |
Why?
|
Electrolytes | 1 | 2022 | 274 | 0.050 |
Why?
|
Pandemics | 4 | 2022 | 8611 | 0.050 |
Why?
|
Fluoroquinolones | 1 | 2023 | 308 | 0.050 |
Why?
|
Pregnancy | 5 | 2023 | 29742 | 0.050 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2021 | 2532 | 0.050 |
Why?
|
Lung | 1 | 2020 | 9985 | 0.050 |
Why?
|
Aged, 80 and over | 7 | 2021 | 58681 | 0.050 |
Why?
|
Factor Analysis, Statistical | 1 | 2023 | 999 | 0.050 |
Why?
|
Microfibrils | 1 | 2020 | 16 | 0.050 |
Why?
|
Neck Pain | 1 | 2022 | 186 | 0.040 |
Why?
|
Weights and Measures | 1 | 2020 | 41 | 0.040 |
Why?
|
Indians, South American | 1 | 2020 | 34 | 0.040 |
Why?
|
X-Rays | 1 | 2021 | 307 | 0.040 |
Why?
|
Internet | 1 | 2012 | 3082 | 0.040 |
Why?
|
Follow-Up Studies | 5 | 2022 | 39060 | 0.040 |
Why?
|
Primary Health Care | 1 | 2017 | 4653 | 0.040 |
Why?
|
Mycolic Acids | 1 | 2020 | 54 | 0.040 |
Why?
|
Regression Analysis | 2 | 2020 | 6353 | 0.040 |
Why?
|
Asthma | 1 | 2019 | 6172 | 0.040 |
Why?
|
Heredity | 1 | 2020 | 148 | 0.040 |
Why?
|
Hospitals, Public | 1 | 2021 | 201 | 0.040 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2023 | 851 | 0.040 |
Why?
|
Nasopharynx | 1 | 2022 | 394 | 0.040 |
Why?
|
Glycolipids | 1 | 2020 | 204 | 0.040 |
Why?
|
Lipids | 2 | 2021 | 3326 | 0.040 |
Why?
|
Residence Characteristics | 2 | 2022 | 2058 | 0.040 |
Why?
|
Administration, Oral | 2 | 2017 | 3993 | 0.040 |
Why?
|
Bacterial Typing Techniques | 1 | 2019 | 260 | 0.040 |
Why?
|
Drug Repositioning | 1 | 2020 | 231 | 0.040 |
Why?
|
Genes, MDR | 1 | 2018 | 36 | 0.040 |
Why?
|
Self-Help Groups | 1 | 2019 | 188 | 0.040 |
Why?
|
Self Efficacy | 1 | 2022 | 631 | 0.040 |
Why?
|
Automation, Laboratory | 1 | 2018 | 103 | 0.040 |
Why?
|
Health Services | 1 | 2023 | 752 | 0.040 |
Why?
|
Saliva | 1 | 2022 | 820 | 0.040 |
Why?
|
Condoms | 1 | 2019 | 328 | 0.040 |
Why?
|
Lectins, C-Type | 1 | 2021 | 585 | 0.040 |
Why?
|
Antigen-Presenting Cells | 1 | 2021 | 964 | 0.040 |
Why?
|
Hospitals, General | 1 | 2021 | 795 | 0.040 |
Why?
|
Gender Identity | 1 | 2023 | 757 | 0.040 |
Why?
|
Gene Expression Profiling | 2 | 2024 | 9405 | 0.030 |
Why?
|
Skin Tests | 1 | 2019 | 637 | 0.030 |
Why?
|
Sequence Analysis, DNA | 2 | 2019 | 4711 | 0.030 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 1 | 2019 | 477 | 0.030 |
Why?
|
Conserved Sequence | 1 | 2019 | 1165 | 0.030 |
Why?
|
Reproducibility of Results | 3 | 2020 | 20052 | 0.030 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 2018 | 241 | 0.030 |
Why?
|
Genetic Variation | 2 | 2024 | 6548 | 0.030 |
Why?
|
Mutation | 2 | 2019 | 29915 | 0.030 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2019 | 823 | 0.030 |
Why?
|
Spirometry | 1 | 2019 | 923 | 0.030 |
Why?
|
Biological Evolution | 1 | 2021 | 1074 | 0.030 |
Why?
|
Urinalysis | 1 | 2018 | 368 | 0.030 |
Why?
|
Pregnant Women | 1 | 2020 | 562 | 0.030 |
Why?
|
Educational Status | 1 | 2023 | 2513 | 0.030 |
Why?
|
Electronic Health Records | 1 | 2012 | 4761 | 0.030 |
Why?
|
Gene Expression | 2 | 2019 | 7583 | 0.030 |
Why?
|
Exercise Therapy | 1 | 2022 | 919 | 0.030 |
Why?
|
Gene Expression Regulation | 2 | 2024 | 11894 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2017 | 10747 | 0.030 |
Why?
|
Protein Multimerization | 1 | 2019 | 979 | 0.030 |
Why?
|
Gene Rearrangement | 1 | 2019 | 1122 | 0.030 |
Why?
|
Risk Assessment | 3 | 2020 | 23883 | 0.030 |
Why?
|
Social Environment | 1 | 2019 | 1022 | 0.030 |
Why?
|
Entamoeba | 1 | 2013 | 5 | 0.030 |
Why?
|
Endolimax | 1 | 2013 | 6 | 0.030 |
Why?
|
Blastocystis hominis | 1 | 2013 | 6 | 0.030 |
Why?
|
Vitamin A | 1 | 2017 | 613 | 0.030 |
Why?
|
Carotenoids | 1 | 2017 | 620 | 0.030 |
Why?
|
Giardia lamblia | 1 | 2013 | 23 | 0.030 |
Why?
|
Structure-Activity Relationship | 1 | 2019 | 3069 | 0.030 |
Why?
|
Antigen Presentation | 1 | 2019 | 1254 | 0.030 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2016 | 627 | 0.030 |
Why?
|
Appointments and Schedules | 1 | 2018 | 441 | 0.030 |
Why?
|
Biological Assay | 1 | 2016 | 626 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2021 | 2322 | 0.030 |
Why?
|
Poisson Distribution | 1 | 2014 | 505 | 0.030 |
Why?
|
Bacteriological Techniques | 1 | 2014 | 279 | 0.030 |
Why?
|
Gene Frequency | 1 | 2020 | 3612 | 0.030 |
Why?
|
Diabetes Complications | 1 | 2019 | 1317 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2021 | 3156 | 0.030 |
Why?
|
Algorithms | 2 | 2023 | 13959 | 0.030 |
Why?
|
Patient Compliance | 1 | 2022 | 2685 | 0.020 |
Why?
|
Interpersonal Relations | 1 | 2019 | 1433 | 0.020 |
Why?
|
Overweight | 1 | 2023 | 2410 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2020 | 6233 | 0.020 |
Why?
|
Protein Conformation | 1 | 2019 | 3966 | 0.020 |
Why?
|
Self Report | 1 | 2023 | 3712 | 0.020 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2018 | 803 | 0.020 |
Why?
|
Radiography | 1 | 2022 | 6955 | 0.020 |
Why?
|
Multicenter Studies as Topic | 1 | 2016 | 1705 | 0.020 |
Why?
|
Health Expenditures | 1 | 2023 | 2348 | 0.020 |
Why?
|
Computer Systems | 1 | 2012 | 470 | 0.020 |
Why?
|
Disease Transmission, Infectious | 1 | 2016 | 557 | 0.020 |
Why?
|
Adolescent Behavior | 1 | 2019 | 1184 | 0.020 |
Why?
|
Counseling | 1 | 2019 | 1541 | 0.020 |
Why?
|
Family | 1 | 2021 | 3188 | 0.020 |
Why?
|
Information Systems | 1 | 2012 | 397 | 0.020 |
Why?
|
Genome-Wide Association Study | 2 | 2020 | 12604 | 0.020 |
Why?
|
Geographic Information Systems | 1 | 2012 | 281 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2018 | 15225 | 0.020 |
Why?
|
Monocytes | 1 | 2019 | 2570 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2379 | 0.020 |
Why?
|
Genetic Loci | 1 | 2019 | 2612 | 0.020 |
Why?
|
Empathy | 1 | 2014 | 473 | 0.020 |
Why?
|
Anti-Retroviral Agents | 1 | 2019 | 1780 | 0.020 |
Why?
|
Time Factors | 3 | 2017 | 39873 | 0.020 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2018 | 932 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2017 | 4839 | 0.020 |
Why?
|
Housing | 1 | 2014 | 666 | 0.020 |
Why?
|
Models, Molecular | 1 | 2019 | 5410 | 0.020 |
Why?
|
Epidemiologic Studies | 1 | 2012 | 670 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2019 | 6493 | 0.020 |
Why?
|
Health Policy | 1 | 2021 | 2675 | 0.020 |
Why?
|
Pain Measurement | 1 | 2018 | 3527 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2021 | 3586 | 0.020 |
Why?
|
Data Collection | 1 | 2017 | 3322 | 0.020 |
Why?
|
Mental Health | 1 | 2022 | 3232 | 0.020 |
Why?
|
CD4 Lymphocyte Count | 1 | 2013 | 2569 | 0.020 |
Why?
|
Protein Binding | 1 | 2019 | 9312 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2019 | 3615 | 0.020 |
Why?
|
Survival Analysis | 1 | 2020 | 10112 | 0.020 |
Why?
|
Body Weight | 1 | 2017 | 4603 | 0.020 |
Why?
|
Program Development | 1 | 2012 | 1297 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2020 | 12440 | 0.020 |
Why?
|
Checklist | 1 | 2012 | 827 | 0.020 |
Why?
|
Risk | 1 | 2017 | 9599 | 0.020 |
Why?
|
Language | 1 | 2014 | 1532 | 0.020 |
Why?
|
Environmental Exposure | 1 | 2019 | 4411 | 0.010 |
Why?
|
Hospitalization | 1 | 2024 | 10653 | 0.010 |
Why?
|
Depression | 1 | 2023 | 8057 | 0.010 |
Why?
|
Alcohol Drinking | 1 | 2016 | 4020 | 0.010 |
Why?
|
Genomics | 1 | 2019 | 5789 | 0.010 |
Why?
|
Substance-Related Disorders | 1 | 2019 | 4402 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2014 | 3561 | 0.010 |
Why?
|
Developing Countries | 1 | 2014 | 2866 | 0.010 |
Why?
|
Research Design | 1 | 2017 | 6154 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2017 | 7985 | 0.010 |
Why?
|
Obesity | 1 | 2023 | 12870 | 0.010 |
Why?
|
Quality of Life | 1 | 2022 | 13286 | 0.010 |
Why?
|
Chronic Disease | 1 | 2015 | 9266 | 0.010 |
Why?
|
Diet | 1 | 2017 | 8003 | 0.010 |
Why?
|
Models, Statistical | 1 | 2014 | 5070 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2016 | 15785 | 0.010 |
Why?
|
Mental Disorders | 1 | 2017 | 6803 | 0.010 |
Why?
|
HIV-1 | 1 | 2013 | 6850 | 0.010 |
Why?
|
Prognosis | 1 | 2016 | 29558 | 0.010 |
Why?
|
United States | 1 | 2023 | 72140 | 0.010 |
Why?
|
Animals | 1 | 2023 | 167777 | 0.010 |
Why?
|